Real World Effectiveness of Oral Semaglutide in Thailand Participants With Type 2 Diabetes

NCT06507475 · Completed

Last updated 2026-05-28

This clinical trial is testing how well the diabetes medication semaglutide, taken as a pill, works in real-world conditions to lower blood sugar levels in adults with type 2 diabetes in Thailand.

Status Completed The study has finished.

Type Observational

Participants 209 people

Who can join Ages 18+ · all sexes

Timeline Started 2024-09 · est. completion 2024-12

Where 1 site · Thailand

What this study is testing ClinicalTrials.gov NCT06507475 ↗

Description as written by the study sponsor.

This study aims to describe the effectiveness of oral semaglutide on glycemic control and body weight control and describe characteristics of type 2 diabetes (T2D) adult patients who are being treated with oral semaglutide in Thailand. Data of eligible patients with T2D will be collected via electronic medical record or paper-format chart review to assess the effectiveness of oral semaglutide. Total study duration for the individual patient will be six months from baseline. The study duration expands within the window period will be 12 months from baseline which will be the optional visit.

Treatments tested

Semaglutide also known as Rybelsus Drug

Participants treated with commercially available oral semaglutide according to local label and to routine clinical practice at the discretion of the treating physician.

Main thing measured	Change in Glycated Haemoglobin (HbA1c)
Sponsor	Novo Nordisk A/S
Conditions studied	Diabetes Mellitus, Type 2
GLP-1 drugs	semaglutide

Full protocol, eligibility, and contacts on ClinicalTrials.gov NCT06507475 ↗